The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. Mark Lawler

Prof. Mark Lawler is a member of the CDDF Board of Directors

Mark Lawler is associate pro-vice-chancellor, professor of Digital Health, and chair in Translational Cancer Genomics, Queen’s University Belfast.

Prof. Lawler is an internationally renowned scientist with over 200 papers including key publications in the highest impact journals. His work has been recognised by numerous national and international awards. He is Associate Director of Health Data Research Wales-Northern Ireland which is driving innovative precision medicine and public health approaches through the use of Big Data. He is Scientific Director of DATA-CAN, the UK’s National Health Data Research Hub for Cancer. He is also Chair of the International Cancer Benchmarking Partnership which deploys data intelligence to help underpin improved outcomes for cancer patients globally.

Prof. Lawler has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was architect of the European Cancer Patient’s Bill of Rights, which he launched in the European Parliament with colleagues on World Cancer Day 2014. The Bill of Rights received the 2018 European Health Award, a prestigious award for partnerships that yield real health impact in Europe. His work on addressing inequalities and access issues in relation to cancer care formed the centrepiece in the development by the European Cancer Organisation of the European Code of Cancer Practice, which he launched (virtually) with EU Health and Food Safety Commissioner Stella Kyriakides and colleagues in Brussels in September 2020

Prof. Lawler’s work on Covid-19 and its impact on cancer services and cancer patients has received international attention and he co-chairs the European Cancer Organisation’s (E.C.O) Special Focussed Network on Covid-19 and cancer, which launched its 7-Point plan to Build Back Better (and smarter) from Covid. He presented recent data on Covid’s impact on cancer in Europe to the Europe Beating Cancer Committee in the European Parliament and launched E.C.Os pan European Time To Act Campaign to ensure that Covid-19 does not stop us from tackling cancer. The work on Covid-19 and cancer also received the prestigious Royal College of Physicians Excellence in Patient Care Award, which recognises the impressive work that doctors do to deliver patient-centred care through education, policy, clinical practice and research. He recently received the Irish Association for Cancer Research’s Outstanding Contribution to cancer research award, for his pioneering work on cancer research and cancer care on the island of Ireland.

In his spare time (if he has any!) Prof. Lawler performs an acclaimed One Man Show on the Irish Writer James Joyce, which he does to raise money for charity.


View current disclosure here


Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70